Tsung H. Lin
Taichung Hospital(TW)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Cell Adhesion Molecules Research, Rheumatoid Arthritis Research and Therapies, Cellular Mechanics and Interactions, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Integrin-mediated Activation of MAP Kinase Is Independent of FAK: Evidence for Dual Integrin Signaling Pathways in Fibroblasts(1997)244 cited
- → Cell Anchorage Permits Efficient Signal Transduction Between Ras and Its Downstream Kinases(1997)224 cited
- → Integrin-mediated Tyrosine Phosphorylation and Cytokine Message Induction in Monocytic Cells(1995)219 cited
- → Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition(2016)189 cited
- → Integrin-mediated Activation of MEK and Mitogen-activated Protein Kinase Is Independent of Ras(1996)185 cited
- → Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( S )-2,2-Difluorocyclopropyl)((1 R ,5 S )-3-(2-((1-methyl-1 H -pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)(2018)170 cited
- → Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases(2018)163 cited
- → Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans(2017)160 cited
- → PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor(2019)157 cited
- → Janus-Kinase-3-Dependent Signals Induce Chromatin Remodeling at the Ifng Locus during T Helper 1 Cell Differentiation(2008)131 cited